243 related articles for article (PubMed ID: 27387453)
1. The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice.
Hess JA; Zhan B; Torigian AR; Patton JB; Petrovsky N; Zhan T; Bottazzi ME; Hotez PJ; Klei TR; Lustigman S; Abraham D
PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004797. PubMed ID: 27387453
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.
George PJ; Hess JA; Jain S; Patton JB; Zhan T; Tricoche N; Zhan B; Bottazzi ME; Hotez PJ; Abraham D; Lustigman S
PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007730. PubMed ID: 31525197
[TBL] [Abstract][Full Text] [Related]
3. Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity.
MacDonald AJ; Tawe W; Leon O; Cao L; Liu J; Oksov Y; Abraham D; Lustigman S
Parasite Immunol; 2004 Jan; 26(1):53-62. PubMed ID: 15198646
[TBL] [Abstract][Full Text] [Related]
4. Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus.
Abraham D; Leon O; Leon S; Lustigman S
Infect Immun; 2001 Jan; 69(1):262-70. PubMed ID: 11119514
[TBL] [Abstract][Full Text] [Related]
5. Linear epitopes in Onchocerca volvulus vaccine candidate proteins and excretory-secretory proteins.
Lagatie O; Verheyen A; Van Dorst B; Batsa Debrah L; Debrah A; Stuyver LJ
Parasite Immunol; 2018 Nov; 40(11):e12587. PubMed ID: 30188578
[TBL] [Abstract][Full Text] [Related]
6. The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age.
Cho-Ngwa F; Liu J; Lustigman S
PLoS Negl Trop Dis; 2010 Aug; 4(8):e800. PubMed ID: 20808763
[TBL] [Abstract][Full Text] [Related]
7. Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model.
Hess JA; Zhan B; Bonne-Année S; Deckman JM; Bottazzi ME; Hotez PJ; Klei TR; Lustigman S; Abraham D
Int J Parasitol; 2014 Aug; 44(9):637-46. PubMed ID: 24907553
[TBL] [Abstract][Full Text] [Related]
8. DNA immunization with Onchocerca volvulus genes, Ov-tmy-1 and OvB20: serological and parasitological outcomes following intramuscular or GeneGun delivery in a mouse model of onchocerciasis.
Harrison RA; Bianco AE
Parasite Immunol; 2000 May; 22(5):249-57. PubMed ID: 10792764
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccine encoding the moonlighting protein Onchocerca volvulus glyceraldehyde-3-phosphate dehydrogenase (Ov-GAPDH) leads to partial protection in a mouse model of human filariasis.
Steisslinger V; Korten S; Brattig NW; Erttmann KD
Vaccine; 2015 Oct; 33(43):5861-5867. PubMed ID: 26320419
[TBL] [Abstract][Full Text] [Related]
10. A four-antigen mixture for rapid assessment of Onchocerca volvulus infection.
Burbelo PD; Leahy HP; Iadarola MJ; Nutman TB
PLoS Negl Trop Dis; 2009; 3(5):e438. PubMed ID: 19436728
[TBL] [Abstract][Full Text] [Related]
11. Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure.
Makepeace BL; Jensen SA; Laney SJ; Nfon CK; Njongmeta LM; Tanya VN; Williams SA; Bianco AE; Trees AJ
PLoS Negl Trop Dis; 2009 Nov; 3(11):e544. PubMed ID: 19901988
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an Onchocerca volvulus L3-specific larval antigen, Ov-ALT-1.
Joseph GT; Huima T; Lustigman S
Mol Biochem Parasitol; 1998 Oct; 96(1-2):177-83. PubMed ID: 9851616
[No Abstract] [Full Text] [Related]
13. Development of a recombinant vaccine against human onchocerciasis.
Abraham D; Graham-Brown J; Carter D; Gray SA; Hess JA; Makepeace BL; Lustigman S
Expert Rev Vaccines; 2021 Nov; 20(11):1459-1470. PubMed ID: 34488533
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection.
Arumugam S; Wei J; Liu Z; Abraham D; Bell A; Bottazzi ME; Hotez PJ; Zhan B; Lustigman S; Klei TR
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004586. PubMed ID: 27045170
[TBL] [Abstract][Full Text] [Related]
15. Characterizing Reactivity to
Feeser KR; Cama V; Priest JW; Thiele EA; Wiegand RE; Lakwo T; Feleke SM; Cantey PT
Am J Trop Med Hyg; 2017 Sep; 97(3):666-672. PubMed ID: 28722605
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an OV-16 IgG4 Enzyme-Linked Immunosorbent Assay in Humans and Its Application to Determine the Dynamics of Antibody Responses in a Non-Human Primate Model of
Cama VA; McDonald C; Arcury-Quandt A; Eberhard M; Jenks MH; Smith J; Feleke SM; Abanyie F; Thomson L; Wiegand RE; Cantey PT
Am J Trop Med Hyg; 2018 Oct; 99(4):1041-1048. PubMed ID: 30062989
[TBL] [Abstract][Full Text] [Related]
17. CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions.
Lustigman S; MacDonald AJ; Abraham D
Int J Parasitol; 2003 Sep; 33(11):1161-71. PubMed ID: 13678632
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity induced by vaccination with Onchocerca volvulus tropomyosin in rodents.
Taylor MJ; Jenkins RE; Bianco AE
Parasite Immunol; 1996 May; 18(5):219-25. PubMed ID: 9229374
[TBL] [Abstract][Full Text] [Related]
19. Impaired antibody responses and loss of reactivity to Onchocerca volvulus antigens by HIV-seropositive onchocerciasis patients.
Tawill SA; Gallin M; Erttmann KD; Kipp W; Bamuhiiga J; Büttner DW
Trans R Soc Trop Med Hyg; 1996; 90(1):85-9. PubMed ID: 8730320
[TBL] [Abstract][Full Text] [Related]
20. Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to
Ryan NM; Hess JA; Robertson EJ; Tricoche N; Turner C; Davis J; Petrovsky N; Ferguson M; Rinaldi WJ; Wong VM; Shimada A; Zhan B; Bottazzi ME; Makepeace BL; Gray SA; Carter D; Lustigman S; Abraham D
Vaccines (Basel); 2023 Jul; 11(7):. PubMed ID: 37515028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
